相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome
P. Restituto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot Study
Matilda Florentin et al.
ANGIOLOGY (2010)
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes
Alfonso Bellia et al.
ATHEROSCLEROSIS (2010)
Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: Beneficial or detrimental?
Niki Katsiki et al.
ATHEROSCLEROSIS (2010)
Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Vasilios G. Athyros et al.
CURRENT DRUG TARGETS (2010)
Visfatin/PBEF and Atherosclerosis-Related Diseases
Theodosios D. Filippatos et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Effects of Lipid-Lowering Drugs on Adiponectin
Apostolos Perelas et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
Michael S. Kostapanos et al.
Current Vascular Pharmacology (2010)
Effect of Pioglitazone on Energy Intake and Ghrelin in Diabetic Patients
Corby K. Martin et al.
DIABETES CARE (2010)
Effect of Meglitinides on Postprandial Ghrelin Secretion Pattern in Type 2 Diabetes Mellitus
Natalia Rudovich et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
Alterations of Insulin Resistance and the Serum Adiponectin Level in Patients with Type 2 Diabetes Mellitus Under the Usual Antihypertensive Dosage of Telmisartan Treatment
Yoshinobu Fuke et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
Circulating adiponectin level is associated with major adverse cardiovascular events in type 2 diabetic patients with coronary artery disease
Wei-Chin Hung et al.
ENDOCRINE JOURNAL (2010)
Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus
Nobuaki Ozaki et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients (Publication with Expression of Concern. See vol. 19, 2018)
Giuseppe Derosa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Lipid-lowering agents and new onset diabetes mellitus
Vasilios G. Athyros et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs
Kwang Kon Koh et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Effects of a Fish-Based Diet on the Serum Adiponectin Concentration in Young, Non-Obese, Healthy Japanese Subjects
Keiko Kondo et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Valsartan Increases Circulating Adiponectin Levels without Changing HOMA-IR in Patients with Type 2 Diabetes Mellitus and Hypertension
J-M Lee et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Effects of Lifestyle Measures, Antiobesity Agents, and Bariatric Surgery on Serological Markers of Inflammation in Obese Patients
Konstantinos Tziomalos et al.
MEDIATORS OF INFLAMMATION (2010)
Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
Nikolaos P. E. Kadoglou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain
Gregory Aubert et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
Giuseppe Derosa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Production and Secretion of Adiponectin from 3T3-L1 Adipocytes: Comparison of Antihypertensive Drugs
Raphaelle Brody et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Adiponectin translation is increased by the PPARγ agonists pioglitazone and ω-3 fatty acids
Anannya Banga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Leptin resistance: a prediposing factor for diet-induced obesity
Philip J. Scarpace et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance
Axel Linke et al.
ATHEROSCLEROSIS (2009)
Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals
Michelle A. Micallef et al.
ATHEROSCLEROSIS (2009)
Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression
Le Thi Kim Chung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity
Christopher D. Morrison et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Metformin increases plasma ghrelin in Type 2 diabetes
Matthew P. Doogue et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effect of Cilostazol Treatment on Adiponectin and Soluble CD40 Ligand Levels in Diabetic Patients With Peripheral Arterial Occlusion Disease
Ching-Jung Hsieh et al.
CIRCULATION JOURNAL (2009)
Combination of an ACE Inhibitor and Indapamide Improves Blood Pressure Control, but Attenuates the Beneficial Effects of ACE Inhibition on Plasma Adiponectin in Patients With Essential Hypertension
Shao-Sung Huang et al.
CIRCULATION JOURNAL (2009)
Effect of Carvedilol on Plasma Adiponectin Concentration in Patients With Chronic Heart Failure
Masayuki Yamaji et al.
CIRCULATION JOURNAL (2009)
Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes
M. von Eynatten et al.
CLINICAL ENDOCRINOLOGY (2009)
Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes
M. van Hoek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis
Yun Hu et al.
DIABETES & VASCULAR DISEASE RESEARCH (2009)
Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study
C. Hohberg et al.
DIABETES OBESITY & METABOLISM (2009)
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes
Yoshimasa Aso et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Pioglitazone Improves Endothelial Function with Increased Adiponectin and High-density Lipoprotein Cholesterol Levels in Type 2 Diabetes
Kyoichiro Tsuchiya et al.
ENDOCRINE JOURNAL (2009)
Total and Acylated Ghrelin Levels in Type 2 Diabetic Patients: Similar Levels Observed after Treatment with Metformin, Pioglitazone or Diet Therapy
S. Kiyici et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin
Rodolfo Gomez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Adiponectin Levels and Risk of Type 2 Diabetes A Systematic Review and Meta-analysis
Shanshan Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Insulin-Stimulated Increase in Serum Leptin Levels Precedes and Correlates with Weight Gain during Insulin Therapy in Type 2 Diabetes
Anne-Marie Aas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons
E. Guillod-Maximin et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Adiponectin and energy homeostasis: consensus and controversy
Sami Dridi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Effect of orlistat on the total ghrelin and leptin levels in obese patients
Y. Ozkan et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan
Li Li Guo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Testosterone Is a Strong Correlate of Ghrelin Levels in Men and Postmenopausal Women
Yona Greenman et al.
NEUROENDOCRINOLOGY (2009)
Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus
Takahiro Araki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus
Ingrid L. Mostad et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients
Shosaku Nomura et al.
PLATELETS (2009)
n-3 PUFA: bioavailability and modulation of adipose tissue function
Jan Kopecky et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2009)
Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
Seung Hwan Han et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Effects of Rosuvastatin and Colestimide on Metabolic Parameters and Urinary Monocyte Chemoattractant Protein-1 in Type 2 Diabetic Patients with Hyperlipidemia
Kohzo Takebayashi et al.
SOUTHERN MEDICAL JOURNAL (2009)
Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus
Konstantinos Tziomalos et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2009)
Effects of Telmisartan and Ramipril on Adiponectin and Blood Pressure in Patients with Type 2 Diabetes
Christian Delles et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin
Giuseppe Derosa et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Effect of pravastatin on the development of diabetes and adiponectin production
Toshiyuki Takagi et al.
ATHEROSCLEROSIS (2008)
Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure
Yumi Miyashita et al.
CARDIOVASCULAR DIABETOLOGY (2008)
The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients
Jacek Lewandowski et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men
Ioanna Gouni-Berthold et al.
CLINICAL ENDOCRINOLOGY (2008)
Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion
John M. Stafford et al.
DIABETES (2008)
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
Helene von Bibra et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
I. Kusaka et al.
DIABETES OBESITY & METABOLISM (2008)
Initial treatment with fixed-dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes
H. S. Chou et al.
DIABETES OBESITY & METABOLISM (2008)
Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia
M IWASE et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus
Hae Jin Kim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes What to add-Insulin glargine or pioglitazone?
Mozhgan Dorkhan et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes
Hiromi Ochiai et al.
ENDOCRINE JOURNAL (2008)
Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study
Erik L. Madsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes
M. Florentin et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults
P. D. Tsitouras et al.
HORMONE AND METABOLIC RESEARCH (2008)
Effects of 12-Month Valsartan Therapy on Glycation and Oxidative Stress Markers in Type 2 Diabetic Subjects With Hypertension
Naoko Komiya et al.
INTERNATIONAL HEART JOURNAL (2008)
Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance
A. N. Dixon et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases
T. Yamauchi et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Pioglitazone reduces atherogenic outcomes in type 2 diabetic patients
Masahiko Igarashi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2008)
Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic type 2 diabetes
C-H. Chu et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women
H. Ebinc et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)
Increased total and high-molecular weight adiponectin after extended-release niacin
Eric P. Plaisance et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: New therapeutic approaches
Satya P. Kalra
NUTRITION (2008)
Effect of a conjugated linoleic acid and ω-3 fatty acid mixture on body composition and adiponectin
Alan A. Sneddon et al.
OBESITY (2008)
Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier
William A. Banks et al.
PEPTIDES (2008)
Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis
Katsuya Dezaki et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinediones
Ozen Oz et al.
ENDOCRINE (2008)
Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure
D. Kovacic et al.
CLINICAL RESEARCH IN CARDIOLOGY (2008)
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms
Marianella Fernandez et al.
DIABETES CARE (2008)
Ghrelin Regulates Insulin Release and Glycemia: Physiological Role and Therapeutic Potential
Toshihiko Yada et al.
CURRENT DIABETES REVIEWS (2008)
G-protein-coupled receptors and islet function - Implications for treatment of type 2 diabetes
Maria Sorhede Winzell et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Plasma ghrelin concentrations in different clinical stages of diabetic complications and glycemic control in Japanese diabetics
Hiroaki Ueno et al.
ENDOCRINE JOURNAL (2007)
Insulin-associated weight gain in diabetes - causes, effects and coping strategies
David Russell-Jones et al.
DIABETES OBESITY & METABOLISM (2007)
Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass
Katarina Kos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: A preliminary study
Bryan A. Whitson et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
Seigo Sugiyama et al.
ATHEROSCLEROSIS (2007)
Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects
O. Ukkola et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2007)
Extended-release niacin raises adiponectin and leptin
Sabine Westphal et al.
ATHEROSCLEROSIS (2007)
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients
Isao Usui et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus
M. Bajaj et al.
DIABETOLOGIA (2007)
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine
Ngozi Erondu et al.
OBESITY (2007)
Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia
C. Otto et al.
ACTA DIABETOLOGICA (2007)
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone
G. Derosa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Weight gain in type 2 diabetes mellitus
A. N. Jacob et al.
DIABETES OBESITY & METABOLISM (2007)
Various dietary fats differentially change the gene expression of neuropeptides involved in body weight regulation in rats
B. Dziedzic et al.
JOURNAL OF NEUROENDOCRINOLOGY (2007)
Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin
Giuseppe Derosa et al.
HYPERTENSION RESEARCH (2007)
Ghrelin interacts with human plasma lipoproteins
Carine De Vriese et al.
ENDOCRINOLOGY (2007)
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome
Mahmut I. Yilmaz et al.
NEPHROLOGY (2007)
Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: Implication in obesity-associated cardiovascular diseases
Hisham S. Elbatarny et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?
C. Bulcao et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2007)
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction
Jeetesh V. Patel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin
Shinichi Takahashi et al.
THROMBOSIS RESEARCH (2007)
Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hypertensive patients with type 2 diabetes
Yutaka Mori et al.
ADVANCES IN THERAPY (2007)
Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus
S. Nomura et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus
Pramod Kumar Sharma et al.
CLINICAL ENDOCRINOLOGY (2006)
Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension
Hyohun Park et al.
CLINICA CHIMICA ACTA (2006)
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients
Roberto Negro et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2006)
The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy
Sachiko Matsumoto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy
Hlroki Fujita et al.
ENDOCRINE JOURNAL (2006)
Brain adipocytokine action and metabolic regulation
Rexford S. Ahima et al.
DIABETES (2006)
Characterization of neuropeptide Y2 receptor protein expression in the mouse brain.: I.: Distribution in cell bodies and nerve terminals
Davor Stanic et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone:: Effects on insulin-resistance, leptin and tumor necrosis factor-α
Giuseppe Derosa et al.
HYPERTENSION RESEARCH (2006)
Insulin treatment and the problem of weight gain in type 2 diabetes
Catherine Carver
DIABETES EDUCATOR (2006)
Adipokines and treatment with niacin
Sabine Westphal et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-α plasma levels in individuals with type 2 diabetes mellitus
Jozef Drzewoski et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Potential role of hypothalamic ghrelin in the pathogenesis of human obesity
M. E. Couce et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Selective imidazoline agonist moxonidine in obese hypertensive patients
AF Sanjuliani et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes
AM Aas et al.
DIABETOLOGIA (2006)
Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF-α levels in Type 2 diabetic patients:: a randomized study
H Shimizu et al.
DIABETIC MEDICINE (2006)
Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels
C Otto et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men
M Möhlig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes
TS Hermann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
CS Chu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients
T Celik et al.
JOURNAL OF HYPERTENSION (2006)
Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes
Y Mori et al.
ENDOCRINE (2006)
Preventing type 2 diabetes in high risk patients: An overview of lifestyle and pharmacological measures
EN Liberopoulos et al.
CURRENT DRUG TARGETS (2006)
Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis
Kunihiko Koshiba et al.
JOURNAL OF MEDICAL INVESTIGATION (2006)
Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia
W. H. Yin et al.
DIABETES & METABOLISM (2006)
Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus
S Nomura et al.
THROMBOSIS RESEARCH (2006)
Leptin: A promising therapeutic target with pleiotropic action besides body weight regulation
Kosmas I. Paraskevas et al.
CURRENT DRUG TARGETS (2006)
Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes
FMAC Martens et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy
GD Tan et al.
DIABETOLOGIA (2005)
Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes
CS Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes
YJ Hung et al.
DIABETIC MEDICINE (2005)
Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: Study from Mumbai, Western India
AR Marita et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes
KK Koh et al.
HYPERTENSION (2005)
Effect of Orlistat on Plasma Leptin Levels and Risk Factors for the Metabolic Syndrome
Dimiter Dimitrov et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2005)
Perspectives in diabetes -: Insulin signaling in the central nervous system -: A critical role in metabolic homeostasis and disease from C-elegans to humans
D Porte et al.
DIABETES (2005)
Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men
S Nordman et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2005)
The influence of adiponectin gene polymorphism on the rosightazone response in patients with type 2 diabetes
ES Kang et al.
DIABETES CARE (2005)
Plasma adiponectin concentrations are independently predicted by fat insulin sensitivity in women and by muscle insulin sensitivity in men
JL Zhang et al.
DIABETES CARE (2005)
Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes
M von Eynatten et al.
DIABETES CARE (2005)
A review of the metabolic effects of sibutramine
TD Filippatos et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Adiponectin and future coronary heart disease events among men with type 2 diabetes
MB Schulze et al.
DIABETES (2005)
The effects of orlistat on metabolic parameters and other cardiovascular risk factors
DN Kiortsis et al.
DIABETES & METABOLISM (2005)
Orlistat for obesity: benefits beyond weight loss
CJ Hsieh et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Lower plasma adiponectin concentration predicts the efficacy of pioglitazone in diabetic patients
S Hiramatsu et al.
DIABETES OBESITY & METABOLISM (2004)
Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines
G Valsamakis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Characterization of neuropeptide YY2 and Y5 receptor expression in the mouse hypothalamus
SO Fetissov et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin
H Kobayashi et al.
CIRCULATION RESEARCH (2004)
Ghrelin secretion is modulated in a nutrient- and gender-specific manner
Y Greenman et al.
CLINICAL ENDOCRINOLOGY (2004)
Neuropeptide Y, ubiquitous and elusive
BA Chronwall et al.
PEPTIDES (2004)
Leptin effects on pancreatic β-cell gene expression and function
J Seufert
DIABETES (2004)
Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia
G Frühbeck et al.
OBESITY SURGERY (2004)
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients
Y Miyazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Weight gain during insulin therapy in patients with type 2 diabetes mellitus
S Heller
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
NPY and Y receptors: lessons from transgenic and knockout models
S Lin et al.
NEUROPEPTIDES (2004)
Identifying pathways involved in leptin-dependent aggregation of human platelets
A Corsonello et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Adiposity signaling and biological defense against weight gain: Absence of protection or central hormone resistance?
MW Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes
MB Schulze et al.
DIABETES CARE (2004)
Short-term effects of gastric bypass surgery on circulating ghrelin levels
R Morínigo et al.
OBESITY RESEARCH (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes
LA Cassis et al.
ENDOCRINOLOGY (2004)
Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy
DM Putz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus
A Katsuki et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression
XF Huang et al.
DIABETES OBESITY & METABOLISM (2004)
Adiponectin acts in the brain to decrease body weight
Y Qi et al.
NATURE MEDICINE (2004)
Triglycerides induce leptin resistance at the blood-brain barrier
WA Banks et al.
DIABETES (2004)
Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models
H Herzog
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect
N Satoh et al.
DIABETES CARE (2003)
Adiponectin: More than just another fat cell hormone?
M Chandran et al.
DIABETES CARE (2003)
Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes
S Nagasaka et al.
DIABETES CARE (2003)
Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients
C Anderwald et al.
DIABETES (2003)
Leptin and body fat in type 2 diabetes and monodrug therapy
WI Sivitz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects
M Faraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase
NJ Beaumont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy
SA Phillips et al.
DIABETES (2003)
Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects
T Tsunekawa et al.
DIABETES CARE (2003)
Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients
T Okumura et al.
DIABETES & METABOLISM (2003)
Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans
JQ Purnell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Obesity, adiponectin and vascular inflammatory disease
N Ouchi et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein
H Nishizawa et al.
DIABETES (2002)
Delayed short-term secretory regulation of ghrelin in obese animals: Evidenced by a specific RIA for the active form of ghrelin
H Ariyasu et al.
ENDOCRINOLOGY (2002)
Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats
N Murakami et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression
HQ Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
DE Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells
M Murata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients
WS Yang et al.
DIABETES CARE (2002)
Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity
EL Air et al.
NATURE MEDICINE (2002)
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes
M Fasshauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion
Y Date et al.
DIABETES (2002)
Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue
CM Halleux et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats
J Kamegai et al.
DIABETES (2001)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
Leptin levels in diabetic and nondiabetic subjects
P Tatti et al.
ENDOCRINE (2001)
The influence of long-term on plasma leptin in type 2 different diabetic therapies diabetic subjects
CC Huang et al.
ENDOCRINE JOURNAL (2001)
Circulating Ghrelin levels are decreased in human obesity
M Tschöp et al.
DIABETES (2001)
Mechanisms of nutritional and hormonal regulation of lipogenesis
S Kersten
EMBO REPORTS (2001)
A role for ghrelin in the central regulation of feeding
M Nakazato et al.
NATURE (2001)
Ghrelin induces adiposity in rodents
M Tschöp et al.
NATURE (2000)
Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women
T Thomas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Gender-related difference in relationship between insulin resistance and serum leptin level in Japanese type 2 diabetic and non-diabetic subjects
A Hattori et al.
ENDOCRINE JOURNAL (2000)
Leptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus
S Güler et al.
DIABETES OBESITY & METABOLISM (2000)
Role of brain insulin receptor in control of body weight and reproduction
JC Brüning et al.
SCIENCE (2000)
The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: A new exploratory paradigm
D Panarotto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus
A Milewicz et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
K Hotta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Long-term celiprolol therapy lowers fasting plasma leptin levels
K Malminiemi
CARDIOVASCULAR DRUGS AND THERAPY (2000)
Is leptin associated with diabetic retinopathy?
G Uckaya et al.
DIABETES CARE (2000)
Bezafibrate reduces blood glucose in type 2 diabetes mellitus
S Ogawa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in Type 2 diabetic patients
D Worm et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in Type 2 diabetes
L Niskanen et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)
分享论文
